Revisiting the public health implications of the United States–Mexico– Canada agreement

被引：0

作者：

Tolulope Anthony Adekola

机构：

[1] City University of Hong Kong,School of Law

来源：

Globalization and Health | / 16卷

关键词：

Public health; USMCA; Pharmaceutical patent; Biologics;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

This commentary re-examines a recent article by Labonté et al on the recent changes to two relevant provisions relating to patent rights in the final version of the United-States-Mexico-Canada Agreement (USMCA). Although the USMCA’s final revised version does not add more pharmaceutical patent protection than those that already exist in the three trading partners, the agreement has done little to enhance access to generic medicines and biosimilars.

引用